ZA978640B - Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis. - Google Patents

Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.

Info

Publication number
ZA978640B
ZA978640B ZA9708640A ZA978640A ZA978640B ZA 978640 B ZA978640 B ZA 978640B ZA 9708640 A ZA9708640 A ZA 9708640A ZA 978640 A ZA978640 A ZA 978640A ZA 978640 B ZA978640 B ZA 978640B
Authority
ZA
South Africa
Prior art keywords
saborrheic
pyridones
dermatitis
hydroxy
treatment
Prior art date
Application number
ZA9708640A
Inventor
Manfred Bohn
Karl Theodor Kraemer
Astrid Markus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA978640B publication Critical patent/ZA978640B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
ZA9708640A 1996-09-27 1997-09-26 Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis. ZA978640B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19639818A DE19639818A1 (en) 1996-09-27 1996-09-27 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

Publications (1)

Publication Number Publication Date
ZA978640B true ZA978640B (en) 1998-03-27

Family

ID=7807118

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708640A ZA978640B (en) 1996-09-27 1997-09-26 Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.

Country Status (32)

Country Link
EP (1) EP0928183B1 (en)
JP (2) JP2001500884A (en)
KR (1) KR100494207B1 (en)
CN (1) CN1104231C (en)
AR (1) AR008860A1 (en)
AT (1) ATE209891T1 (en)
AU (1) AU716208B2 (en)
BG (1) BG64365B1 (en)
BR (1) BR9711575A (en)
CA (1) CA2267165C (en)
CY (1) CY2362B1 (en)
CZ (1) CZ291485B6 (en)
DE (2) DE19639818A1 (en)
DK (1) DK0928183T3 (en)
ES (1) ES2167721T3 (en)
HK (1) HK1022267A1 (en)
HU (1) HU226955B1 (en)
ID (1) ID21874A (en)
IL (1) IL129141A0 (en)
MA (1) MA24333A1 (en)
MY (1) MY125674A (en)
NO (1) NO312492B1 (en)
NZ (1) NZ334850A (en)
OA (1) OA11028A (en)
PL (1) PL188033B1 (en)
PT (1) PT928183E (en)
RS (1) RS49801B (en)
TR (1) TR199900662T2 (en)
TW (1) TW519491B (en)
UA (1) UA57754C2 (en)
WO (1) WO1998013009A2 (en)
ZA (1) ZA978640B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19639816A1 (en) 1996-09-27 1998-04-02 Hoechst Ag Antifungal agents with high drug release
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
PL2197440T3 (en) 2007-08-31 2013-05-31 Janssen Pharmaceutica Nv Combinations of imazalil and hydroxypyridones
NZ585433A (en) 2007-11-30 2011-11-25 Janssen Pharmaceutica Nv Combinations of fungicidal azoles and pyrion compounds
EP2252147B1 (en) 2008-02-06 2012-12-05 Janssen Pharmaceutica NV Combinations of fludioxonil and pyrion compounds
PL2587920T3 (en) 2010-07-01 2017-01-31 Janssen Pharmaceutica, N.V. Antimicrobial combinations of pyrion compounds with polyethyleneimines
HUE028411T2 (en) * 2010-12-02 2016-12-28 Univ Kansas Prodrugs of 6-cyclohexyl-1-hydroxy-4- methylpyridin-2(1h)-one and derivatives thereof
CN103687582B (en) * 2011-07-19 2016-03-30 露珍细胞再生株式会社 Polyphosphoric acids compositions containing the polyphosphoric acids, the salt of polyphosphoric acids or the solvate of polyphosphoric acids that extract from yeast and preparation method thereof
FR2983858B1 (en) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique NOVEL INHIBITORY COMPOUNDS OF LIPOGENESIS
CN104744359B (en) * 2015-03-06 2017-10-10 上药康丽(常州)药业有限公司 A kind of process for purification of Ciclopirox

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234009C3 (en) * 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Cosmetic preparations
NL8601762A (en) * 1986-07-07 1988-02-01 Bouke Jan Lange METHOD FOR CLEANING AND CONDITIONING AND ANY MEDICINAL TREATMENT OF HAIR AND SCALP, A TWO-PHASE SHAMPOO USABLE FOR THIS PURPOSE AND PACKAGING FOR IT.
AU5096393A (en) * 1992-09-08 1994-03-29 Procter & Gamble Company, The Mild, substantially colorless shampoo composition
DE4333893A1 (en) * 1993-10-05 1995-04-06 Hoechst Ag Cosmetic preparations
FR2722689B1 (en) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique NOVEL COMBINATION PRODUCT COMPRISING AN ANTIFUNGAL AGENT AND CROTAMITON AS A POTENTIALIZER OF THE ACTIVITY OF THE ANTIFUNGAL AGENT, AND DERMATOLOGICAL AND / OR COSMETIC COMPOSITIONS COMPRISING THE SAME

Also Published As

Publication number Publication date
DK0928183T3 (en) 2002-04-02
CZ291485B6 (en) 2003-03-12
BG103260A (en) 2000-01-31
HUP9903811A3 (en) 2001-11-28
BR9711575A (en) 1999-08-24
NO991460L (en) 1999-03-25
PT928183E (en) 2002-05-31
CZ107599A3 (en) 1999-06-16
AU716208B2 (en) 2000-02-24
PL332603A1 (en) 1999-09-27
YU13499A (en) 2001-09-28
HK1022267A1 (en) 2000-08-04
ATE209891T1 (en) 2001-12-15
HU226955B1 (en) 2010-03-29
NO991460D0 (en) 1999-03-25
CA2267165C (en) 2003-12-16
KR20000048613A (en) 2000-07-25
CY2362B1 (en) 2004-06-04
AR008860A1 (en) 2000-02-23
TW519491B (en) 2003-02-01
UA57754C2 (en) 2003-07-15
HUP9903811A1 (en) 2000-04-28
IL129141A0 (en) 2000-02-17
AU4774697A (en) 1998-04-17
JP2001500884A (en) 2001-01-23
WO1998013009A2 (en) 1998-04-02
CN1231595A (en) 1999-10-13
CN1104231C (en) 2003-04-02
RS49801B (en) 2008-06-05
OA11028A (en) 2003-03-06
ES2167721T3 (en) 2002-05-16
NO312492B1 (en) 2002-05-21
CA2267165A1 (en) 1998-04-02
MY125674A (en) 2006-08-30
WO1998013009A3 (en) 1998-05-14
PL188033B1 (en) 2004-11-30
KR100494207B1 (en) 2005-06-13
EP0928183A2 (en) 1999-07-14
BG64365B1 (en) 2004-12-30
DE19639818A1 (en) 1998-04-02
MA24333A1 (en) 1998-04-01
NZ334850A (en) 2001-02-23
TR199900662T2 (en) 1999-06-21
JP2006176540A (en) 2006-07-06
DE59705697D1 (en) 2002-01-17
EP0928183B1 (en) 2001-12-05
ID21874A (en) 1999-08-05

Similar Documents

Publication Publication Date Title
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
ZA97631B (en) Migraine treatment.
ZA9811507B (en) Combination effective for the treatment of impotence.
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
EP0612513A3 (en) External skin treatment composition.
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
ZA972515B (en) Acne treatment.
ZA976350B (en) Treatment of liquid.
ZA973843B (en) Treatment of asthma with TNFR-lg.
ZA974570B (en) Device for the production of sponge iron.
GB9615767D0 (en) Novel treatment
ZA977867B (en) Method of treatment.
ZA975637B (en) Method for the treatment of emesis.
ZA973380B (en) Treatment of washwater.
GB9608657D0 (en) Novel treatment
EP1032266A4 (en) Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis
GB9726223D0 (en) The treatment of materials
ZA978139B (en) Process for the biological-thermal treatment of waste.
ZA974386B (en) New formulation for treatment of thromboembolism.
ZA976071B (en) Process for the monoacylation of hydroxytaxanes.
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
ZA9711116B (en) The treatment of materials.
SI0928183T1 (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
EP0643123A3 (en) Process for the treatment of halogenated hydrocarbons.